PharmaResearch Co., Ltd. Logo

PharmaResearch Co., Ltd.

Develops regenerative medicine, devices & cosmetics using marine biotechnology.

214450 | KO

Overview

Corporate Details

ISIN(s):
KR7214450009
LEI:
Country:
South Korea
Address:
강원도 강릉시 과학단지로 77-19, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmaResearch Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. It develops, produces, and sells a range of products including pharmaceuticals, medical devices, and cosmetics. The company's core technology leverages marine biotechnology to create refined raw materials for cell and tissue regeneration. In addition to its product lines, PharmaResearch also offers consulting services for the development, licensing, and registration of medical products. The company is dedicated to enhancing human health through its innovative regenerative solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-21 00:00
Regulatory News Service
불성실공시법인미지정 (지정유예)
Korean 5.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.3 MB
2025-08-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.7 KB
2025-08-01 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.0 KB
2025-07-31 00:00
Regulatory News Service
불성실공시법인지정예고 (공시번복)
Korean 4.9 KB
2025-07-08 00:00
M&A Activity
기타주요경영사항 (회사분할결정 철회)
Korean 3.4 KB
2025-07-08 00:00
M&A Activity
[기재정정]주요사항보고서(회사분할결정)
Korean 27.3 KB
2025-07-08 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 9.8 KB
2025-06-27 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 13.9 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 9.0 KB
2025-06-20 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.9 KB
2025-06-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 9.0 KB
2025-06-16 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.9 KB
2025-06-13 00:00
Delisting Announcement
주권매매거래정지 (분할)
Korean 4.9 KB
2025-06-13 00:00
M&A Activity
주요사항보고서(회사분할결정)
Korean 49.2 KB

Automate Your Workflow. Get a real-time feed of all PharmaResearch Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmaResearch Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmaResearch Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NuCana plc Logo
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
United States of America
NCNA
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America
NRIX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary
NUTEX
NutriBand Inc. Logo
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
United States of America
NTRB
Nuvalent, Inc. Logo
Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.
United States of America
NUVL
Nuvation Bio Inc. Logo
A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.
United States of America
NUVB
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan
4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland
OBSN
OCULAR THERAPEUTIX, INC Logo
Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.
United States of America
OCUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.